Aurigene Pharmaceutical to Invest in India’s Genome Valley

Aurigene Discovery Technologies Limited, a research, development, and manufacturing services organization and subsidiary of Dr. Reddy's Laboratories, announced plans to construct a development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors in Genome Valley at Hyderabad, India. As the first phase of investment, Aurigene will invest $40 million...

India’s Bharat Serums Expands Manufacturing Facilities

Mumbai-headquartered Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telengana. The company is owned by Advent, an American private equity fund. Spread across 10 acres, the  $22 million manufacturing facility will increase the company's capacity to produce injectables...

Biological E Invest $234 Million to Expand Vaccine Production

Privately held Indian company, Biological E  is investing $234 million in  their three facilities in the Genome Valley of Hyderabad, India. The new infusion of funds will enhance the production capacity by five billion doses, increasing the cumulative capacity to about 14 billion doses per year. The company claims that...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries